Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Dietary carbohydrate restriction in the treatment of diabetes and metabolic syndrome is based on an underlying principle of control of insulin secretion and the theory that insulin resistance is a response to chronic hyperglycemia and hyperinsulinemia. As such, the theory is intuitive and has substantial experimental support. It has generally been opposed by health agencies because of concern that carbohydrate will be replaced by fat, particularly saturated fat, thereby increasing the risk of cardiovascular disease as dictated by the so-called diet-heart hypothesis. Here we summarize recent data showing that, in fact, substitution of fat for carbohydrate generally improves cardiovascular risk factors. Removing the barrier of concern about dietary fat makes carbohydrate restriction a reasonable, if not the preferred method for treating type 2 diabetes and metabolic syndrome. We emphasize the ability of low carbohydrate diets to improve glycemic control, hemoglobin A1C and to reduce medication. We review evidence that such diets are effective even in the absence of weight loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boden, G., Sargrad, K., Homko, C., Mozzoli, M., & Stein, T. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00006 · Cited by 542
Krieger, J. W., Sitren, H. S., Daniels, M. J., & Langkamp-Henken, B. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.260 · Cited by 466 · cited 2×
“The literature records numerous studies of the effectiveness of diets based on carbohydrate restriction for weight loss in normal subjects, and patients with metabolic syndrome or diabetes and such interventions are at least as effective as low-fat diets and generally substantially better (Reviews: (5,21,22)); in stud…”
BackgroundGannon, M. C., & Nuttall, F. Q. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2375 · Cited by 428
Forsythe, C. E., Phinney, S. D., Fernandez, M. L., Quann, E. E., Wood, R. J., Bibus, D. M., Kraemer, W. J., Feinman, R. D., & Volek, J. S. (2008) · Lipids · doi:10.1007/s11745-007-3132-7 · Cited by 371
Self-citationSeparate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia
Krauss, R. M., Blanche, P. J., Rawlings, R. S., Fernstrom, H. S., & Williams, P. T. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.5.1025 · Cited by 321 · cited 1×
“Notable in the Table is that benefits were seen in interventions designed to maintain body weight, although small amounts of weight were lost anyway in one of the low carbohydrate arm, a phenomenon reported by others (18).”
BackgroundModification of Lipoproteins by Very Low-Carbohydrate Diets
Volek, J. S., Sharman, M. J., & Forsythe, C. E. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.6.1339 · Cited by 159 · cited 1×
“The increase in fatty acids leads to disruptions in TG synthesis and processing and the abnormalities collectively referred to as atherogenic dyslipidemia (high TG, low HDL, small dense LDL, increased apoB/ apoA1 ratio (Reviews: (7,8)).”
BackgroundSelf-citation
Cited by
Effect of diet on type 2 diabetes mellitus: a review
Khazrai, Y. M., Defeudis, G., & Pozzilli, P. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2515 · Cited by 626
Carbohydrate Restriction has a More Favorable Impact on the Metabolic Syndrome than a Low Fat Diet
Volek, J. S., Phinney, S. D., Forsythe, C. E., Quann, E. E., Wood, R. J., Puglisi, M. J., Kraemer, W. J., Bibus, D. M., Fernandez, M. L., & Feinman, R. D. (2009) · Lipids · doi:10.1007/s11745-008-3274-2 · Cited by 397
“Several recent diet comparisons have been published showing that CRDs are at least as effective as LFDs on weight loss, lipid profile, and other health markers [18, 27, 44–46] (reviews: [14, 23, 47, 48]), the most recent being a two-year study from Shai et al.”
BackgroundSelf-citationBarona, J., Aristizabal, J. C., Blesso, C. N., Volek, J. S., & Fernandez, M. L. (2012) · The Journal of Nutrition · doi:10.3945/jn.112.162743 · Cited by 173
Self-citationVolek, J. S., Kackley, M. L., & Buga, A. (2024) · Current Nutrition Reports · doi:10.1007/s13668-024-00548-6 · Cited by 48
Self-citation
Metadata
- Authors
- Feinman, R. D., & Volek, J. S.
- Venue
- Scandinavian Cardiovascular Journal
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 42
- Issue
- 4
- Pages
- 256-263
- ISSN
- 1401-7431 (ISSN-L)
- 1651-2006
- OpenAlex
- W1983950995
- Cited by
- 47
- References
- 6
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome. https://app.cochat.ai/papers/10.1080/14017430802014838
- The paper
- Feinman, R. D., & Volek, J. S. (2008). Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome. Scandinavian Cardiovascular Journal. https://doi.org/10.1080/14017430802014838
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.